Stevens-Johnson Syndrome Cymbalta Risk
Cymbalta Can Cause Serious Skin Disease. Cymbalta, the antidepressant and anti-anxiety medication manufactured by Eli Lilly, can cause a serious and sometimes fatal skin condition called Stevens-Johnson Syndrome (SJS). Some medications cause SJS, causing the skin to burn from the inside out and leading to blisters, severe rashes and … [Read more...]
Cialis Side Effects May Cause Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Cialis Side Effects Injury Lawsuits. Cialis, manufactured by Eli Lilly & Co. and Icos Corp. was approved on November 21, 2003 by the FDA. Cialis is used to treat male impotency and Erectile Dysfunction. On July 11, 2005, the FDA approved a label change for the Cialis after three reported cases of Non-Arteritic Anterior Ischemic … [Read more...]
Xigris Side Effects Could Result In Blood Infections Lawsuits
LATEST NEWS: Xigris May Cause Blood Infections. October 25,2011: Health Canada to withdraw Xigris from Canadian Market! The Canadian Health Department (Health Canada) issued a statement informing Canadians that it is working with Eli Lilly Canada to withdraw Xigris (drotrecogin alfa) from the Canadian market, in light of the … [Read more...]
Strattera Side Effects May Result In Suicide Lawsuits
Strattera Side Effects Increase Suicidal Thoughts. Eli Lilly declared on September 28, 2005 that they are adding a black-box warning to its attention deficit (AD) medication ‘Strattera’. The new warning will claim that the drug increase suicidal thoughts among youths. The FDA issued a health advisory on ‘Strattera’ after evaluating … [Read more...]
Actos Makers Continue to Face Bladder Cancer Claims
Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to patients and their physicians. Court records indicate that a new Actos lawsuit was filed in June … [Read more...]
Olanzapine May Cause Serious Skin Condition
Antipsychotic Medicine Olanzapine Cause Serious Skin Condition. The U.S. Food and Drug Administration (FDA) has issued a warning regarding the antipsychotic medicine olanzapine stating it can cause a "rare but serious" condition. Olanzapine is available under the Eli Lilly & Co. brand names of Zyprexa, Zyprexa Zydis, Zyprexa … [Read more...]
Eli Lilly Abandons Development of New Cholesterol Drug after Poor Performance in Phase 3 Trial
A Cholesterol Drug Fail To Perform Well. On Monday, drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to perform well in a phase 3 clinical trial. The drug, evacetrapib, was designed to prevent heart attacks and other cardiovascular problems by modifying cholesterol … [Read more...]
Eli Lilly Abandons Development of New Cholesterol Drug
Eli Lilly Ceased Work For New Cholesterol Drug. Drug maker Eli Lilly announced that it was ceasing work on a new cholesterol-lowering drug, after the drug failed to perform well in a phase 3 clinical trial. The drug, evacetrapib, was designed to prevent heart attacks and other cardiovascular problems by modifying cholesterol … [Read more...]
FDA Warns about Testosterone Drugs for Men
The Food and Drug Administration (FDA) has issued a warning to doctors about testosterone-boosting drugs for men. The popular treatments have not been established as safe or effective for treating common signs of aging like low libido and fatigue. The FDA warned that the drugs may increase the risk of heart attack, stroke and other … [Read more...]
Eli Lilly Faces Lawsuit Over Axiron
Lawsuit Over Testosterone Drug Axiron. In a recently filed lawsuit, Eli Lilly is accused of deceptively marketing the testosterone replacement drug Axiron while failing to warn about the risk of heart attack and stroke. The suit, which was filed in federal court in Newark, New Jersey, alleges that Lilly engaged in aggressive … [Read more...]
Blue Cross Sues Takeda
Bladder cancer risks associated with the Type 2 diabetes. Blue Cross and Blue Shield of Massachusetts filed subrogation actions last week in the Louisiana multidistrict litigation (MDL) over the bladder cancer risks associated with the Type 2 diabetes drug Actos. Blue Cross seeks to recover the cost of medical bills for hundreds of … [Read more...]
Takeda, Eli Lilly In Illinois Actos Lawsuit
Actos Lawsuit Filed In Illinois. Another Actos bladder cancer lawsuit has been filed, this time in Illinois state court. It joins at least 54 others that have been filed in federal courts throughout the country. According to the Madison County Record, Robert Bettorf began taking Actos in 2007, and was diagnosed with bladder … [Read more...]
Zyprexa Articles Ghostwritten
Eli Lilly Zyprexa, Articles Ghostwritten. Zyprexa maker Eli Lilly apparently asked doctors to put their names on articles written by company officials in an effort to promote the drug. According to Bloomberg.com, the company's alleged strategy to use ghostwritten articles to increase Zyprexa sales was revealed when more … [Read more...]
Merck & Co Follows Eli Lilly in Disclosing Physician Fees
Eli Lilly Disclosing Physician Fees. Earlier this week we reported that Eli Lilly and Company will reveal how much money it pays physicians for speeches and consulting, starting next year. Lilly was the first major drug maker to commit to physician payment disclosure, representing the newest example of the pharmaceutical industry's … [Read more...]
Byetta Linked to More Deaths
Byetta Implicated In Deaths. Byetta has been implicated in six deaths, four more than federal regulators reported last week. The additional deaths were revealed late yesterday during a conference call conducted by Amylin Pharmaceuticals Inc. and Eli Lilly & Co, the co-marketers of the diabetes drugs. The companies did report … [Read more...]
Cymbalta Suicide Data
Cymbalta Suicide Data. Cymbalta, an antidepressant made by Eli Lilly, has been linked to suicides. Although suicide is sometimes the tragic outcome of depression, some of those who have committed suicide while taking Cymbalta were not being treated for depression - or for any other mental illness. Unfortunately, despite reports of … [Read more...]
Report: Lilly hid info on Zyprexa
Info About Zyprexa Side Effects. Internal company documents show that Eli Lilly concealed information about side effects of its schizophrenia drug ‘Zyprexa’, The New York Times said Saturday. The Times said it received the documents and e-mails from a lawyer representing patients who have used ‘Zyprexa’. They show that the company … [Read more...]
Lilly Documents Link Prozac to Violence
Lilly Documents Link Prozac to Violence. Eli Lilly & Co. documents linking the antidepressant Prozac to violence have been turned over to the U.S. Food and Drug Administration by the British Medical Journal, the publication says in its Jan. 1 issue. The documents ``appear to suggest a link'' between Lilly's Prozac and suicide … [Read more...]
FDA Criticizes Cymbalta’s Medical Journal Ads
Cymbalta Medical Journal Ads Has Been Scrutinized. Eli Lilly & Co. failed to make the risks of its Cymbalta medicine clear enough in medical journal advertisements that promoted the drug to treat nerve pain caused by diabetes, U.S. regulators said. In a letter to Lilly posted Wednesday on the U.S. Food and Drug Administration … [Read more...]
Lilly to Add Strattera Labeling Warning
Strattera Black Box Warning. A pharmaceutical maker volunteers to add a black-box warning noting rare occurrences of suicidal thoughts in young patients taking its popular ADHD drug. Eli Lilly and Co. announced September 29 that it was complying with a request from the U.S. Food and Drug Administration (FDA) to add a "black-box" … [Read more...]
Cymbalta to Carry Expanded Warning
Cymbalta May Cause Serious Liver-Related Problems. The Food and Drug Administration (FDA) and Eli Lilly have notified healthcare professionals of a significant revision to the PRECAUTIONS/Hepatotoxicity section of the prescribing information for ‘Cymbalta’ (duloxetine hydrochloride); Lilly’s antidepressant indicated for treatment of … [Read more...]
ADHD Drug, Straterra, Suicidal Thoughts
ADHD Drug, Straterra Can Cause Suicidal Thoughts. Eli Lilly & Company is warning that its ADHD drug, Straterra, may cause suicidal thoughts in children and adolescents. In a press release dated today, Lilly reported that its Straterra clinical trials database had identified a small but statistically significant increased risk … [Read more...]
A Warning to Eli Lilly With Respect to Strattera Ad
False And Misleading Eli Lilly Strattera TV Ad. In a letter to Eli Lilly, the FDA has warned the pharmaceutical giant that its television advertisement for Strattera “is false or misleading because it inadequately communicates the indication for ‘Strattera’ and minimizes the risk associated with Strattera.” broader indication for … [Read more...]
Lilly to Settle Zyprexa Claims
Zyprexa Liability Claims. Eli Lilly announced late Thursday that it will settle about three-quarters of the liability claims stemming from its Zyprexa schizophrenia drug. Lilly will establish a fund not to exceed $690 million for plaintiffs who agree to settle their claims. The number of claimants covered by the settlement is … [Read more...]
Eli Lilly Agrees to Zyprexa Settlement
Claims Against Schizophrenia Medication Zyprexa. Eli Lilly and Co. said late Thursday that it has entered into an agreement in principle to settle about 8,000, or 75%, of the claims against the company related to its schizophrenia medication, Zyprexa. When finalized, the agreement will also result in the dismissal of claims … [Read more...]
How Lilly Gilded Prozac’s Profile
The Popular Antidepressant Prozac's Profile. This spring, Jeff Weise shot himself dead after taking the popular antidepressant Prozac. He scored national headlines because he took nine innocent people down with him in the worst school shooting rampage since Columbine. Some now wonder whether Weise's antidepressant rather than … [Read more...]
FDA, Eli Lilly Warn of Sepsis Drug Risk
FDA Warn of Sepsis Drug Risk. The Food and Drug Administration and Eli Lilly Co. (LLY) issued a warning Thursday about a treatment used in patients with severe sepsis, saying it might increase their risk of death, based on an analysis of two clinical trial databases. The warning, however, only applies to patients who have had … [Read more...]
Zyprexa Comes Under Legal Fire
Eli Lilly Zyprexa Is Under Fire. A very popular prescription drug is under fire and you need to know about it. Zyprexa, manufactured by Eli Lilly, is being accused of causing everything from diabetes to panchreatis, even death. WVLT TV's Jane Nowiski tells us more about the drug and what you can do if you're taking it. "Studies … [Read more...]
Lawsuit Against Eli Lilly and Company
Parker & Waichman, LLP (www.yourlawyer.com) and Douglas & London LLP announce the filing of a lawsuit against Eli Lilly and Company (NYSE: LLY - News) on behalf of all persons residing in the United States who used Zyprexa. The lawsuit was filed on April 16, 2004 in the United States District Court for the Eastern … [Read more...]
PW Files Claims Against Eli Lilly and Company
Parker & Waichman Filed Claims Against Eli Lilly And Company. Parker & Waichman LLP (www.yourlawyer.com) filed claims against Eli Lilly and Company (NYSE: LLY - News) on behalf of three individuals who claim to have sustained severe side-effects from Zyprexa. The claims were filed in Federal District Court in the Eastern District of … [Read more...]
Wall Street Journal Questions Safety of Lilly Drug
Lilly Drug Serious Side Effect. It brought in nearly $1 billion in sales last year. Zyprexa, Eli Lilly and Company's blockbuster treatment for schizophrenia is under growing questions about a potentially serious side effect. The front page of the Wall Street Journal raises the question, does Zyprexa and other drugs like it cause … [Read more...]
Lilly Procedure Prompts FDA Concern
Eli Lilly Quality Control Problems. INDIANAPOLIS-BASED ELI LILLY AND COMPANY HAS MADE NO SECRET ABOUT IT'S QUALITY CONTROL PROBLEMS. THE FDA IS STALLING THE RELEASE OF AT LEAST ONE NEW DRUG, UNTIL ALL IS WELL AT THE PLANTS... AND WITHOUT THAT NEW MEDICINE, THE COMPANY IS TAKING A FINANCIAL HIT. SO WHY IS THE GOVERNMENT … [Read more...]
Warnings Added to Diabetes Drugs
GlaxoSmithKline and Eli Lilly & Company Diabetes Drugs May Cause Liver Damage. GlaxoSmithKline and Eli Lilly & Company have added warnings about heart and liver risks to the labels of their diabetes drugs, which are similar to a medication that was withdrawn from the market in 2000 because of links to fatal liver damage. The Food … [Read more...]
